New Experimental Therapy for A.L.S. Approved in Canada June 14, 2022 Auto Bot amyotrophic lateral sclerosis, Canada, Clinical Trials, Food and Drug Administration, Health Canada, United States, your-feed-science 0 The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.